Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRICYS), Madrid, Spain.
Servicio de Geriatría, Hospital Clínico San Carlos, Madrid, Spain.
J Am Med Dir Assoc. 2024 Sep;25(9):105151. doi: 10.1016/j.jamda.2024.105151. Epub 2024 Jul 14.
Older adults with dementia commonly receive multiple medications and have higher hospitalization rates, elevating the risk of potentially inappropriate prescribing and in-hospital adverse drug reactions (ADRs). There is limited evidence examining ADRs in older adults with dementia during hospitalization.
Our aim was to assess the association between dementia and incidence of ADRs during hospitalization and to identify prevalent types of ADRs and medications linked to ADRs.
Secondary analysis of the SENATOR trial database, which was a randomized controlled trial of an intervention to reduce ADRs in older inpatients with multimorbidity.
A total of 1537 patients (47.2% females) with a mean age of 78.1 years were recruited from 6 European hospitals.
Sociodemographic data, functional status, cognitive status, clinical information, and ADR-related outcomes were extracted from the SENATOR database. Inpatients with dementia were identified based on prior International Classification of Diseases, Tenth Revision (ICD-10), dementia diagnosis, receiving acetylcholinesterase inhibitors or memantine, or a Mini-Mental State Examination score ≤24 at admission without concurrent delirium.
Among participants, 392 (25.5%) were identified as having dementia. The proportion of patients with probable or certain incident in-hospital ADRs was similar between the groups with and without dementia (22.4% vs 25.4%, P > .05). However, in-hospital rates of probable or certain ADRs from 12 common categories were less frequently identified in patients with dementia compared to those without (19.4% vs 23%, P = .025). Major constipation (6.4% vs 9.9%, P = .03) and acute dyspepsia, nausea, or vomiting (2.8% vs 5%, P = .03) were less commonly observed ADRs in patients with dementia.
We did not observe an increased risk of in-hospital ADRs among inpatients with dementia. However, ADRs related to the gastrointestinal tract and identified by subjective symptoms were less frequently identified in this group. This study lays the groundwork for developing new tools for ADR diagnosis for older patients with dementia.
患有痴呆症的老年人通常会服用多种药物,且住院率较高,这增加了潜在不合理用药和住院期间药物不良反应(ADR)的风险。目前,有关痴呆症老年人住院期间 ADR 的证据有限。
我们旨在评估痴呆症与住院期间 ADR 发生率之间的关联,并确定常见的 ADR 类型和与 ADR 相关的药物。
对 SENATOR 试验数据库的二次分析,该数据库是一项针对患有多种合并症的老年住院患者减少 ADR 的干预措施的随机对照试验。
共有 1537 名患者(47.2%为女性)参与,平均年龄为 78.1 岁,他们来自欧洲的 6 家医院。
从 SENATOR 数据库中提取人口统计学数据、功能状态、认知状态、临床信息和与 ADR 相关的结果。根据先前的国际疾病分类、第十版(ICD-10)、痴呆症诊断、接受乙酰胆碱酯酶抑制剂或美金刚或入院时简易精神状态检查评分≤24 且无同时发生的谵妄,确定痴呆症住院患者。
在参与者中,392 人(25.5%)被确定为患有痴呆症。有或无痴呆症的患者中,可能或确定的住院期间 ADR 比例相似(22.4%比 25.4%,P>.05)。然而,与无痴呆症的患者相比,患有痴呆症的患者中,12 种常见类别的可能或确定 ADR 的住院率较低(19.4%比 23%,P=.025)。主要便秘(6.4%比 9.9%,P=.03)和急性消化不良、恶心或呕吐(2.8%比 5%,P=.03)是痴呆症患者较少发生的 ADR。
我们没有观察到痴呆症住院患者发生院内 ADR 的风险增加。然而,与胃肠道相关的 ADR 以及通过主观症状识别的 ADR 在该组中较少发生。这项研究为开发针对痴呆症老年患者的新 ADR 诊断工具奠定了基础。